Shanghai Fudan University Huashan Hospital

Brain-Computer Interface Advances Enable Speech Synthesis and Action Control in Epilepsy Patient

4 months ago

• A 43-year-old epilepsy patient with a brain tumor can now communicate and control actions through computer decoding of her thoughts, marking a significant BCI advancement. • NeuroXess and Huashan Hospital collaborated on the project, showcasing the potential of flexible electrode BCI technologies for restoring basic life functions. • Clinical trials in China are expanding, with NeuroXess achieving 71% accuracy in decoding 142 Chinese syllables within seven days of surgery. • Ethical considerations, including data privacy and patient safety, are being emphasized as BCI technology advances toward broader clinical application.

Chinese BCI System Achieves Breakthrough in Language Decoding

5 months ago

• A Chinese research team has achieved a breakthrough in brain-computer interface (BCI) technology using a domestically developed, invasive flexible BCI system. • The BCI system demonstrated high-precision, real-time movement intention and language decoding in a clinical trial with a brain injury patient. • The patient could convert thoughts into Chinese text with 71% accuracy for 142 common syllables within seven days of training. • This advancement signifies China's progress to world-class standards in BCI, potentially aiding patients with motor and language impairments.

China's NEO Brain-Computer Interface Set for Large-Scale Clinical Trials

5 months ago

• China's NEO brain-computer interface (BCI) device is set to begin large-scale clinical trials next year, enrolling 30-50 spinal cord injury patients across 10 centers. • The NEO device, developed by Neuracle Technology and Tsinghua University, has already undergone three successful human implantations this year. • A recent surgery enabled a paralyzed patient to regain the ability to move their arms and perform simple tasks via mind control. • Clinical data from these trials will be submitted to regulatory authorities to seek approval for commercialization of the BCI product.